SpringerLink
Log in

Dacarbazine/ipilimumab/nivolumab

Elevated liver enzyme levels, autoimmune colitis and hepatotoxicity: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. ICSR is valid for Patient# 1, 3, 4 and 5.

Reference

  • Sagiv O, et al. Immunotherapy with Programmed Cell Death 1 Inhibitors for 5 Patients with Conjunctival Melanoma. JAMA Ophthalmology 136: 1236-1241, No. 11, 1 Nov 2018. Available from: URL: http://doi.org/10.1001/jamaophthalmol.2018.3488 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dacarbazine/ipilimumab/nivolumab. Reactions Weekly 1734, 168 (2019). https://doi.org/10.1007/s40278-019-56293-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-56293-2

Search

Navigation